Prevention of bladder cancer recurrence by retinoic acid-ketoconazole: a promising strategy?
Lotan
Yair
Y
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA. yair.lotan@UTSouthwestern.edu
Lotan
Reuben
R
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D007654:Ketoconazole / Q000008:administration & dosage*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D014212:Tretinoin / Q000008:administration & dosage*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D014212:Tretinoin; D007654:Ketoconazole